Contributors
Hideki Adachi, Colin Berry(University of Glasgow), Paolo Ascenzi(Roma Tre University), Michael W. W. Adams(University of Georgia), Ulrich Baumann(Medizinische Hochschule Hannover), Alexey A. Agranovsky(Russian Academy of Sciences), Lilia M. Babé, Kyunghye Ahn, Sean M. Amberg, Teaster Baird, Toni Antalis(QIMR Berghofer Medical Research Institute), Wolfgang Baumeister(Max Planck Institute of Biochemistry), Alexander Y. Amerik, Robert Belas, Martin O. Bergö(Karolinska Institutet), S. Paul Bajaj, Cornel Badorff(Goethe University Frankfurt), A. John Barrett(National Institutes of Health), Patrizia Aducci(University of Rome Tor Vergata), Kazunari Arima, Zach Adam(University of Arizona), Alı́ Alejo(Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria), Osao Adachi(Yamaguchi University), Rohan T. Baker, Yoshinori Akiyama(Shizuoka City Shimizu Hospital), Suneel Apte(Cleveland Clinic), Germán Andrés(Consejo Superior de Investigaciones Científicas), I. P. Baskova, Nathan N. Aronson, Francesc Avilés(Universitat Autònoma de Barcelona), Agnieszka Banbula(Jagiellonian University), G. A. Bannikov(The Ohio State University), David A. Agard(University of California, San Francisco), Michael J. Adang(University of Georgia), Shan Bai, Susan C. Baker, Ibrahim M. Adham(Universitätsmedizin Göttingen), Robert K. Andrews, Gérard J. Arlaud, Michael C. Berndt(Australian National University), Teruhiko Beppu, David S. Auld, Yasuhisa Asano, Karl Bauer, Ernst M. Bergmann, Marcus Ballinger, William M. Awad, Anne Beauvais(Institut Pasteur), Marina T. Assakura, John D. Bartlett(The Ohio State University)
Cited by 0
Related Papers
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
|The Lancet|2016|4.8k
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
|Nature Medicine|2018|1.2k
Randomized Trial of Preventive Angioplasty in Myocardial Infarction
|New England Journal of Medicine|2013|1k